LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Sight Sciences (NASDAQ: SGHT)

Follow NASDAQ:SGHT Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ SGHT Sight Sciences
Encrantz Staffan / director, 10 percent owner:
05/29/2025
Buy
$3.59
60,128
$216K
1.16M
NASDAQ SGHT Sight Sciences
Encrantz Staffan / director, 10 percent owner:
05/28/2025
Buy
$3.52
26,715
$94K
1.10M
NASDAQ SGHT Sight Sciences
Encrantz Staffan / director, 10 percent owner:
05/27/2025
Buy
$3.44
41,346
$142K
1.07M
NASDAQ SGHT Sight Sciences
Raheja Manohar K. / officer: EVP, Research & Development
05/16/2025
Buy
$3.02
12,767
$39K
167,767
NASDAQ SGHT Sight Sciences
Bauerlein Alison / officer: Chief Financial Officer
05/19/2025
Sell
$3.48
13,066
$45K
636,728
NASDAQ SGHT Sight Sciences
Link Matthew / officer: Chief Commercial Officer
05/16/2025
Buy
$3.02
6,631
$20K
837,182
NASDAQ SGHT Sight Sciences
HAYDEN JEREMY B. / officer: Chief Legal Officer
04/02/2025
Sell
$2.31
9,395
$22K
275,481
NASDAQ SGHT Sight Sciences
Badawi Paul / director, officer: President and CEO
04/01/2025
Sell
$2.30
24,174
$56K
6.01M
NASDAQ SGHT Sight Sciences
Link Matthew / officer: Chief Commercial Officer
04/02/2025
Sell
$2.31
5,042
$12K
830,551
NASDAQ SGHT Sight Sciences
Badawi David / director, officer: Chief Technology Officer
04/01/2025
Sell
$2.30
5,980
$14K
1.84M
NASDAQ SGHT Sight Sciences
Bauerlein Alison / officer: Chief Financial Officer
04/02/2025
Sell
$2.31
19,397
$45K
649,794

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous